Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oramed Pharma
(NQ:
ORMP
)
2.170
-0.060 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Oramed Pharma
< Previous
1
2
3
Next >
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
August 19, 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
3 Micro-Cap Moonshots for Fearless Investors
July 08, 2024
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 12, 2024
Via
Benzinga
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024
May 09, 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023
March 07, 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Top 4 Health Care Stocks That May Crash This Quarter
February 02, 2024
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
August 05, 2023
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
June 23, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
Via
Benzinga
Dow Tumbles 250 Points; CarMax Posts Upbeat Results
June 23, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98%...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 16, 2023
Via
Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Why Oramed Pharmaceuticals Shares Are Trading Higher Today
May 15, 2023
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 19, 2023
On Thursday, 29 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 17, 2023
Tuesday saw 9 companies set new 52-week lows.
Via
Benzinga
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%
January 12, 2023
U.S. stocks traded higher toward the end of trading, following the release of inflation data.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
January 17, 2023
Via
Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 12, 2023
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
Wall Street Divided After Key Inflation Reading
January 12, 2023
Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI).
Via
Talk Markets
US Stocks Turn Higher; Dow Jumps 200 Points
January 12, 2023
U.S. stocks turned higher midway through trading, following the release of inflation data.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 12, 2023
On Thursday, 13 stocks hit new 52-week lows.
Via
Benzinga
Why Oramed Pharmaceuticals Stock Is Crashing Today
January 12, 2023
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
Via
The Motley Fool
AVCT Stock Falls as American Virtual Cloud Technologies Files for Bankruptcy
January 12, 2023
American Virtual Cloud Technologies (AVCT) stock is taking a beating on Thursday as the company, and two subsidiaries, file for bankruptcy.
Via
InvestorPlace
Why Is Oramed (ORMP) Stock Down 75% Today?
January 12, 2023
Oramed (ORMP) stock is falling hard Thursday after announcing a Phase 3 clinical trial of its diabetes treatment missed its primary endpoint.
Via
InvestorPlace
Dow Drops 150 Points; US Inflation Rate Slows In December
January 12, 2023
U.S. stocks traded lower this morning, following the release of inflation data.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 12, 2023
Via
Benzinga
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
January 12, 2023
Gainers Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 12, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
Oramed Pharma Shares Sink After Diabetes Candidate Fails In Phase 3 Study
January 12, 2023
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) announced top-line results from its Phase 3 trial (ORA-D-013-1) comparing the efficacy of ORMD-0801 to placebo in patients with Type 2 Diabetes (T2D) at 26...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.